Streetbeat News

Price Targets

GEHC

GE HealthCare Techs (NASDAQ:GEHC) has received mixed analyst ratings in the last quarter with 1 bullish, 2 indifferent, and 1 bearish. The average price target is $75.5, representing an upside from the current price of $69.3. This target has decreased by 7.93% from the previous target of $82.00. Analyst ratings are provided quarterly and can include forecasts for company metrics.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:00 pm

CYBR

CyberArk Software (NASDAQ:CYBR) has received updated analyst ratings in the last quarter, with 5 bullish, 9 somewhat bullish, and no indifferent, somewhat bearish, or bearish ratings. The average 12-month price target for CYBR is $205.71, with a high of $250.00 and a low of $185.00, marking a 9.03% increase from the previous target of $188.67. Analysts' ratings are based on predictions of a company's future earnings and revenue, and are updated quarterly or after major company events.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:00 pm

SYK

Stryker (NYSE:SYK) has received 6 analyst ratings in the last quarter, with 3 bullish and 3 indifferent, and no bearish ratings. The average 12-month price target for Stryker is $322.83, with a high of $345.00 and a low of $297.00. This target has increased by 7.52% over the past month. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:00 pm

ADBE

Adobe (NASDAQ:ADBE) has received 33 analyst ratings in the last quarter, with an average price target of $623.3, representing an upside from the current price of $611.2. The ratings include 9 bullish, 16 somewhat bullish, and 8 indifferent, with no bearish or somewhat bearish ratings. The current average price target has increased by 9.06% from the previous target of $571.50.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:00 pm

ISRG

Over the past 3 months, 10 Wall Street analysts have published their opinions on Intuitive Surgical (NASDAQ:ISRG), with 3 bullish, 5 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for ISRG is $338.3, with a high of $390.00 and a low of $300.00. This target has decreased by 4.67% from the previous average of $354.86. Analysts typically update their ratings quarterly and may provide additional metrics such as earnings and revenue forecasts.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:00 pm

CLF

CMA

HUM

IYH

On CNBC's 'Halftime Report Final Trades,' experts shared their final trades, including iShares U.S. Healthcare ETF (IYH), Comerica Incorporated (CMA), Cleveland-Cliffs Inc. (CLF), and Humana Inc. (HUM). Goldman Sachs analyst Ryan Nash maintained a Neutral rating on Comerica and raised the price target from $45 to $50. Cleveland-Cliffs announced price increases for steel products last month. Humana closed higher on Friday amid reports of a potential merger with Cigna Group. Comerica, iShares U.S. Healthcare ETF, Cleveland-Cliffs, and Humana all saw share price increases on Friday.

Portfolio Pulse from Lisa Levin

December 04, 2023 | 1:53 pm

FNV

BMO Capital analyst Jackie Przybylowski has maintained an Outperform rating on Franco-Nevada but reduced the price target from C$214 to C$200.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:49 pm

FM.TO

BMO Capital analyst Jackie Przybylowski has maintained an Outperform rating on First Quantum Minerals but reduced the price target from C$28.5 to C$20.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:47 pm

DTE

BMO Capital analyst James Thalacker has maintained a 'Market Perform' rating on DTE Energy (NYSE:DTE) and increased the price target from $107 to $111.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:45 pm

CSTM

BMO Capital analyst Katja Jancic has maintained an Outperform rating on Constellium (NYSE:CSTM) and increased the price target from $22 to $25.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 1:43 pm